Exercise and atorvastatin for metastatic cancer outcomes
Treatments studied
Part of Cancer, Hormones & metabolism, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This trial tests whether a structured exercise program, along with the cholesterol medicine atorvastatin, can improve outcomes in people with metastatic prostate, breast, ovarian, or kidney cancer. It may help by reducing inflammation and supporting physical function during cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have metastatic prostate, breast, ovarian, or kidney cancer confirmed by tests and scans, and you just started first-line cancer drug treatment
- You must be able to do physical activity safely (exercise may be adjusted to your abilities)
- You can follow study instructions and have the support needed for exercise and clinic visits
- You are not currently taking cholesterol-lowering medicine (statins like atorvastatin) going into the study
- You can safely take atorvastatin—no severe liver or kidney problems and no past major trouble tolerating cholesterol medicines
- If you are a woman in the study, you must use reliable birth control during the intervention (and the study excludes pregnancy or breastfeeding)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a structured exercise program can help men with metastatic prostate cancer who are on hormone therapy. It looks at changes in cancer cells and overall well-being.
This trial studies whether a structured lifestyle intervention (such as exercise and related behavior changes) can benefit people with metastatic prostate cancer who are currently on hormone treatment. It may help by improving health and functioning while you continue standard cancer therapy.
This trial tests adding a common cholesterol medicine (atorvastatin) to standard chemotherapy for advanced ovarian cancer. The goal is to see if the combination can help your immune system fight the cancer better.
This Phase 2 study tests whether a structured exercise and lifestyle program, tracked with a Fitbit, can reduce cardiovascular (heart) risk in men with prostate cancer on hormone therapy. It also checks whether this is safe and feasible while monitoring symptoms and fitness changes.
This trial tests whether a supervised exercise and nutrition program can improve well-being for people with ovarian cancer who are taking a maintenance drug called a PARP inhibitor after finishing their first round of chemotherapy. Participation may help manage side effects and support overall health.
This trial studies whether a structured exercise and lifestyle (diet and activity) program can help women with ovarian or endometrial cancer during chemotherapy. You may be assigned to the lifestyle program or usual care to compare outcomes.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.